Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle. Yang J, Li Y, Zong C, Zhang Q, et al. Invest Ophthalmol Vis Sci 2021;62:11.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang J, Li Y, Zong C, Zhang Q, et al. Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle. Invest Ophthalmol Vis Sci 2021;62:11.
PMID: 34901994